BioCryst Pharmaceuticals
BCRX
#4939
Rank
โ‚ฌ1.74 B
Marketcap
6,78ย โ‚ฌ
Share price
-2.10%
Change (1 day)
12.00%
Change (1 year)

P/S ratio for BioCryst Pharmaceuticals (BCRX)

P/S ratio as of November 2026 (TTM): 1.99

According to BioCryst Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -4.22. At the end of 2026 the company had a P/S ratio of 2.17.

P/S ratio history for BioCryst Pharmaceuticals from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20262.1720.18%
20251.81-49.01%
20243.54-4.28%
20233.70-53.16%
20227.90-50.16%
202115.9-78.53%
202073.8578.44%
201910.9-74.69%
201843.0124.18%
201719.28.28%
201617.712.94%
201515.7-75.6%
201464.3148.13%
201325.9842.78%
20122.75-51.66%
20115.6952.58%
20103.73-2.01%
20093.80310.36%
20080.9267-71.87%
20073.29-93.95%
200654.4-98.29%
2005> 1000-77.51%
2004> 100018759.03%
200374.9684.31%
20029.5552.86%
20016.25

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Gilead Sciences
GILD
6.71 236.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2.26 13.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
0.8218-58.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
12.9 547.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
3.21 61.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
> 1000 712,812.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
0.4767-76.09%๐Ÿ‡บ๐Ÿ‡ธ USA